ROLE OF NK CYTOTOXIC FACTOR NKCF IN NK CYTOTOXICITY
NK 细胞毒性因子 NKCF 在 NK 细胞毒性中的作用
基本信息
- 批准号:3173360
- 负责人:
- 金额:$ 12.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1983
- 资助国家:美国
- 起止时间:1983-07-01 至 1989-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Previous studies of the natural killer (NK) lytic mechanism have provided
evidence for the stimulus secretion model and led to the postulation that
lytic mediators are transferred from the effector to the target cell.
Subsequent work in our laboratory has demonstrated that soluble natural
killer cytotoxic factors (NKCF) can be detected in the supernatant of
effector cells stimulated with NK targets. These factors are NK specific
and lyse only NK sensitive targets. Further studies have shown that NKCF
conform with known characteristics of the NK CMC reaction and we have
postulated that NKCF plays a role in NK CMC cytotoxicity function. The
following model for NK CMC was then proposed by which, following effector
target cell binding, the target stimulates the effector to release NKCF.
These factors then bind to and lyse the target cells. Preliminary studies
have shown that NKCF are glycoproteins and can be fractionated on HPLC
gel-filtration into cytotoxic fractions of molecular weight 20-30
kilodaltons. Furthermore, we have been able to generate xeno and
monoclonal antibodies that can inhibit NK CMC sctivity and in a few
instances neutralize NKCF activity. In the proposal we plan to: 1)
further characterize and biochemically purify NKCF to homogeneity, 2)
characterize antibodies (poly or monoclonal) specific for NKCF, and examine
their role in NK CMC reactions, and 3) in collaboration with other
investigators, compare NKCF with recently described cytolytic granules or
cytotoxins and lymphotoxins derived from NK and CTL lines. We will use
conventional methods of protein purification and structure analysis.
Conventional and monoclonal antibodies will be generated against NKCF and
will be characterized for their role in blocking NK CMC reactions. The
studies proposed are significant and unique in the field of CMC. They are
also clinically important since they describe naturally derived antitumor
cytolytic molecules that may be relevant in immunotherapy. (LB)
以往对自然杀伤(NK)的裂解机制的研究提供了
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BENJAMIN BONAVIDA其他文献
BENJAMIN BONAVIDA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BENJAMIN BONAVIDA', 18)}}的其他基金
PROGRAMMING FOR LYSIS STAGE IN NK CYTOTOXICITY
NK 细胞毒性裂解阶段的编程
- 批准号:
3185063 - 财政年份:1987
- 资助金额:
$ 12.56万 - 项目类别:
PROGRAMMING FOR LYSIS STAGE IN NK CYTOTOXICITY
NK 细胞毒性裂解阶段的编程
- 批准号:
3185064 - 财政年份:1987
- 资助金额:
$ 12.56万 - 项目类别:
PROGRAMMING FOR LYSIS STAGE IN NK CYTOTOXICITY
NK 细胞毒性裂解阶段的编程
- 批准号:
3185065 - 财政年份:1987
- 资助金额:
$ 12.56万 - 项目类别:
PROGRAMMING FOR LYSIS STAGE IN NK CYTOTOXICITY
NK 细胞毒性裂解阶段的编程
- 批准号:
3185061 - 财政年份:1987
- 资助金额:
$ 12.56万 - 项目类别:
ROLE OF NK CYTOTOXIC FACTOR NKCF IN NK CYTOTOXICITY
NK 细胞毒性因子 NKCF 在 NK 细胞毒性中的作用
- 批准号:
3173361 - 财政年份:1983
- 资助金额:
$ 12.56万 - 项目类别:
ROLE OF NK CYTOTOXIC FACTOR NKCF IN NK CYTOTOXICITY
NK 细胞毒性因子 NKCF 在 NK 细胞毒性中的作用
- 批准号:
3173359 - 财政年份:1983
- 资助金额:
$ 12.56万 - 项目类别:
ROLE OF NK CYTOTOXIC FACTOR NKCF IN NK CYTOTOXICITY
NK 细胞毒性因子 NKCF 在 NK 细胞毒性中的作用
- 批准号:
3173362 - 财政年份:1983
- 资助金额:
$ 12.56万 - 项目类别:
INAPPROPRIATE H-2 (K/D) AND IE/C ANTIGENS ON TUMORS
肿瘤上不适当的 H-2 (K/D) 和 IE/C 抗原
- 批准号:
3169721 - 财政年份:1982
- 资助金额:
$ 12.56万 - 项目类别:
相似海外基金
SBIR Phase I: Antibody Therapy that Targets Neoantigens in Acute Myeloid Leukemia via the Antibody Dependent Cell-mediated Cytotoxicity Mechanism of Natural Killer Cells
SBIR 第一期:通过抗体依赖性细胞介导的自然杀伤细胞的细胞毒性机制,针对急性髓性白血病新抗原的抗体疗法
- 批准号:
2246487 - 财政年份:2023
- 资助金额:
$ 12.56万 - 项目类别:
Standard Grant
Identification of resistant mechanisms of tumor cells against CAR-T cell-mediated cytotoxicity
肿瘤细胞对 CAR-T 细胞介导的细胞毒性的耐药机制的鉴定
- 批准号:
22H02910 - 财政年份:2022
- 资助金额:
$ 12.56万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
New regulators of natural killer cell-mediated cytotoxicity
自然杀伤细胞介导的细胞毒性的新调节剂
- 批准号:
10370297 - 财政年份:2021
- 资助金额:
$ 12.56万 - 项目类别:
Discovery of Novel Epitopes for Antibody Dependent Cell-mediated Cytotoxicity Against HIV-1 Infected Cells
发现抗体依赖性细胞介导的针对 HIV-1 感染细胞的细胞毒性的新表位
- 批准号:
10031027 - 财政年份:2020
- 资助金额:
$ 12.56万 - 项目类别:
Discovery of Novel Epitopes for Antibody Dependent Cell-mediated Cytotoxicity Against HIV-1 Infected Cells
发现抗体依赖性细胞介导的针对 HIV-1 感染细胞的细胞毒性的新表位
- 批准号:
10113530 - 财政年份:2020
- 资助金额:
$ 12.56万 - 项目类别:
Unlocking Envelope: A New Strategy for a Functional Cure Through Antibody-Dependent Cell-Mediated Cytotoxicity
解锁包膜:通过抗体依赖性细胞介导的细胞毒性实现功能性治愈的新策略
- 批准号:
9925499 - 财政年份:2019
- 资助金额:
$ 12.56万 - 项目类别:
Unlocking Envelope: A New Strategy for a Functional Cure Through Antibody-Dependent Cell-Mediated Cytotoxicity
解锁包膜:通过抗体依赖性细胞介导的细胞毒性实现功能性治愈的新策略
- 批准号:
10176380 - 财政年份:2019
- 资助金额:
$ 12.56万 - 项目类别:
Effects of NK cell adaptation to cytomegalovirus and engagement of TIGIT on HIV-specific antibody-dependent cell-mediated cytotoxicity
NK 细胞对巨细胞病毒的适应和 TIGIT 参与对 HIV 特异性抗体依赖性细胞介导的细胞毒性的影响
- 批准号:
400251 - 财政年份:2019
- 资助金额:
$ 12.56万 - 项目类别:
Unlocking Env: A New Strategy for a Functional Cure Through Antibody-Dependent Cell-Mediated Cytotoxicity
解锁 Env:通过抗体依赖性细胞介导的细胞毒性实现功能性治愈的新策略
- 批准号:
9273185 - 财政年份:2017
- 资助金额:
$ 12.56万 - 项目类别:
A NOVEL ASSAY FOR ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY
抗体依赖性细胞介导的细胞毒性的新型检测方法
- 批准号:
8357976 - 财政年份:2011
- 资助金额:
$ 12.56万 - 项目类别:














{{item.name}}会员




